ID DFCI024 AC CVCL_A762 SY DFCI 024; DFCI.024; Dana-Farber Cancer Institute 024 DR Cosmic; 1165894 DR DepMap; ACH-001058 DR GEO; GSM794264 DR PharmacoDB; DFCI024_289_2019 DR Wikidata; Q54831032 RX PubMed=18594010; RX PubMed=20679594; RX PubMed=26929325; RX PubMed=28196595; RX PubMed=29681454; RX PubMed=31068700; WW Info; MCLP; -; https://tcpaportal.org/mclp/ CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: MD Anderson Cell Lines Project. CC HLA typing: A*24:02,33:01:01; B*04:02:01,35:02:01; C*08:02,04:01:01 (PubMed=26929325). CC Omics: Genomics; Whole exome sequencing. CC Omics: Proteomics; Expression; Reverse-phase protein array. CC Omics: Transcriptomics; Microarray. CC Omics: Transcriptomics; RNAseq. CC Omics: Variations; SNP array analysis. CC Discontinued: DepMap; ACH-001058; true. CC Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. ST Source(s): PubMed=20679594 ST Amelogenin: X ST CSF1PO: 11,12 ST D13S317: 11,12 ST D16S539: 8,13 ST D5S818: 10,12 ST D7S820: 9 ST TH01: 6,9.3 ST TPOX: 12 ST vWA: 16,18 DI NCIt; C3512; Lung adenocarcinoma OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Female CA Cancer cell line DT Created: 06-06-12; Last updated: 10-04-25; Version: 18 // RX PubMed=20679594; DOI=10.1093/jnci/djq279; PMCID=PMC2935474; RA Gazdar, Adi F. RA Girard, Luc RA Lockwood, William W. RA Lam, Wan L. RA Minna, John D. RT "Lung cancer cell lines as tools for biomedical discovery and RT research."; RL J. Natl. Cancer Inst. 102:1310-1321(2010). // RX PubMed=26929325; DOI=10.1073/pnas.1521812113; PMCID=PMC4801290; RA Tripathi, Satyendra C. RA Peters, Haley L. RA Taguchi, Ayumu RA Katayama, Hiroyuki RA Wang, Hong RA Momin, Amin RA Jolly, Mohit Kumar RA Celiktas, Muge RA Rodriguez-Canales, Jaime RA Liu, Hui RA Behrens, Carmen RA Wistuba, Ignacio Ivan RA Ben-Jacob, Eshel RA Levine, Herbert RA Molldrem, Jeffrey Joel RA Hanash, Samir M. RA Ostrin, Edwin Justin RT "Immunoproteasome deficiency is a feature of non-small cell lung RT cancer with a mesenchymal phenotype and is associated with a poor RT outcome."; RL Proc. Natl. Acad. Sci. U.S.A. 113:E1555-E1564(2016). // RX PubMed=29681454; DOI=10.1016/j.cell.2018.03.028; PMCID=PMC5935540; RA McMillan, Elizabeth A. RA Ryu, Myung-Jeom RA Diep, Caroline H. RA Mendiratta, Saurabh RA Clemenceau, Jean Rene RA Vaden, Rachel M. RA Kim, Ju-Hwa RA Motoyaji, Takashi RA Covington, Kyle R. RA Peyton, Michael RA Huffman, Kenneth RA Wu, Xiao-Feng RA Girard, Luc RA Sung, Yeojin RA Chen, Pei-Hsaun RA Mallipeddi, Prema Latha RA Lee, Joo Young RA Hanson, Jordan RA Voruganti, Sukesh RA Yu, Yunku RA Park, Sunho RA Sudderth, Jessica RA DeSevo, Christopher RA Muzny, Donna M. RA Doddapaneni, HarshaVardhan RA Gazdar, Adi F. RA Gibbs, Richard Alexander RA Hwang, Tae Hyun RA Heymach, John Victor RA Wistuba, Ignacio Ivan RA Coombes, Kevin Robert RA Williams, Noelle S. RA Wheeler, David A. RA MacMillan, John B. RA DeBerardinis, Ralph J. RA Roth, Michael G. RA Posner, Bruce Arthur RA Minna, John D. RA Kim, Hyun Seok RA White, Michael A. RT "Chemistry-first approach for nomination of personalized treatment in RT lung cancer."; RL Cell 173:864-878.e29(2018). // RX PubMed=18594010; DOI=10.1158/1078-0432.CCR-08-0168; PMCID=PMC3025451; RA Koivunen, Jussi P. RA Mermel, Craig H. RA Zejnullahu, Kreshnik RA Murphy, Carly RA Lifshits, Eugene RA Holmes, Alison J. RA Choi, Hwan Geun RA Kim, Jhingook RA Chiang, Derek Y. RA Thomas, Roman Kurt RA Lee, Jinseon RA Richards, William G. RA Sugarbaker, David John RA Ducko, Christopher Thomas RA Lindeman, Neal I. RA Marcoux, J. Paul 2nd RA Engelman, Jeffrey Adam RA Gray, Nathanael S. RA Lee, Charles RA Meyerson, Matthew Langer RA Janne, Pasi Antero RT "EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung RT cancer."; RL Clin. Cancer Res. 14:4275-4283(2008). // RX PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005; PMCID=PMC5501076; RA Li, Jun RA Zhao, Wei RA Akbani, Rehan RA Liu, Wen-Bin RA Ju, Zhen-Lin RA Ling, Shi-Yun RA Vellano, Christopher P. RA Roebuck, Paul RA Yu, Qing-Hua RA Eterovic, A. Karina RA Byers, Lauren Averett RA Davies, Michael A. RA Deng, Wan-Leng RA Gopal, Y.N. Vashisht RA Chen, Guo RA von Euw, Erika Maria RA Slamon, Dennis Joseph RA Conklin, Dylan RA Heymach, John Victor RA Gazdar, Adi F. RA Minna, John D. RA Myers, Jeffrey N. RA Lu, Yi-Ling RA Mills, Gordon B. RA Liang, Han RT "Characterization of human cancer cell lines by reverse-phase protein RT arrays."; RL Cancer Cell 31:225-239(2017). // RX PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103; RA Ghandi, Mahmoud RA Huang, Franklin W. RA Jane-Valbuena, Judit RA Kryukov, Gregory V. RA Lo, Christopher C. RA McDonald, E. Robert 3rd RA Barretina, Jordi Ginesta RA Gelfand, Ellen T. RA Bielski, Craig M. RA Li, Hao-Xin RA Hu, Kevin RA Andreev-Drakhlin, Alexander Y. RA Kim, Jaegil RA Hess, Julian M. RA Haas, Brian J. RA Aguet, Francois RA Weir, Barbara A. RA Rothberg, Michael V. RA Paolella, Brenton R. RA Lawrence, Michael Scott RA Akbani, Rehan RA Lu, Yi-Ling RA Tiv, Hong L. RA Gokhale, Prafulla C. RA de Weck, Antoine RA Mansour, Ali Amin RA Oh, Coyin RA Shih, Juliann RA Hadi, Kevin RA Rosen, Yanay RA Bistline, Jonathan RA Venkatesan, Kavitha RA Reddy, Anupama RA Sonkin, Dmitriy RA Liu, Manway RA Lehar, Joseph RA Korn, Joshua M. RA Porter, Dale A. RA Jones, Michael D. RA Golji, Javad RA Caponigro, Giordano RA Taylor, Jordan E. RA Dunning, Caitlin M. RA Creech, Amanda L. RA Warren, Allison C. RA McFarland, James M. RA Zamanighomi, Mahdi RA Kauffmann, Audrey RA Stransky, Nicolas RA Imielinski, Marcin RA Maruvka, Yosef E. RA Cherniack, Andrew D. RA Tsherniak, Aviad RA Vazquez, Francisca RA Jaffe, Jacob D. RA Lane, Andrew Alan RA Weinstock, David M. RA Johannessen, Cory M. RA Morrissey, Michael P. RA Stegmeier, Frank RA Schlegel, Robert RA Hahn, William Chun RA Getz, Gad RA Mills, Gordon B. RA Boehm, Jesse S. RA Golub, Todd Robert RA Garraway, Levi Alexander RA Sellers, William Raj RT "Next-generation characterization of the Cancer Cell Line RT Encyclopedia."; RL Nature 569:503-508(2019). //